LEP and steatosis: For example, women with obesity with high levels of leptin develop resistance to its effects rather than sensitivity [214], showing a positive correlation with serum insulin levels, insulin resistance, and liver damage, including both steatosis and inflammation, contributing to MASLD/MASH [214,215].